History-alignment models for bias-aware prediction of virological response to HIV combination therapy

The relevant HIV data sets used for predicting outcomes of HIV combination therapies suffer from several problems: different treatment backgrounds of the samples, uneven representation with respect to the level of therapy experience and uneven therapy representation. Also, they comprise only viral strain(s) that can be detected in the patients’ blood serum. The approach presented in this paper tackles these issues by considering not only the most recent therapies but also the different treatment backgrounds of the samples making up the clinical data sets when predicting the outcomes of HIV therapies. For this purpose, we introduce a similarity measure for sequences of therapies and use it for training separate linear models for predicting therapy outcome for each target sample. Compared to the most commonly used approach that encodes all available treatment information only by specific input features our approach has the advantage of delivering significantly more accurate predictions for therapy-experienced patients and for rare therapies. Additionally, the sample-specific models are more interpretable which is very important in medical applications.

[1]  Sa Azin,et al.  An overview on the 2008 UNAIDS Report on the 2008 UNAIDS Report on the Global AIDS Epidemic. , 2010 .

[2]  Thomas Lengauer,et al.  Multi-task learning for HIV therapy screening , 2008, ICML '08.

[3]  D. Richman,et al.  2022 update of the drug resistance mutations in HIV-1. , 2022, Topics in antiviral medicine.

[4]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[5]  Thomas Lengauer,et al.  Dealing with sparse data in predicting outcomes of HIV combination therapies , 2010, Bioinform..

[6]  Brendan Larder,et al.  The Development of Artificial Neural Networks to Predict Virological response to Combination HIV Therapy , 2007, Antiviral therapy.

[7]  Thomas Lengauer,et al.  Learning from Past Treatments and Their Outcome Improves Prediction of In Vivo Response to Anti-HIV Therapy , 2011, Statistical applications in genetics and molecular biology.

[8]  Thomas Lengauer,et al.  Predicting the response to combination antiretroviral therapy: retrospective validation of geno2pheno-THEO on a large clinical database. , 2009, The Journal of infectious diseases.

[9]  Thomas Lengauer,et al.  Selecting anti-HIV therapies based on a variety of genomic and clinical factors , 2008, ISMB.

[10]  Deenan Pillay,et al.  Update of the Drug Resistance Mutations in HIV-1: December 2008 , 2008 .

[11]  Chih-Jen Lin,et al.  Trust Region Newton Method for Logistic Regression , 2008, J. Mach. Learn. Res..

[12]  Tomaso A. Poggio,et al.  Regularization Networks and Support Vector Machines , 2000, Adv. Comput. Math..

[13]  S. B. Needleman,et al.  A general method applicable to the search for similarities in the amino acid sequence of two proteins. , 1970, Journal of molecular biology.

[14]  D. Richman,et al.  Update of the drug resistance mutations in HIV-1: December 2010. , 2010, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[15]  Thomas Lengauer,et al.  Methods for optimizing antiviral combination therapies , 2003, ISMB.

[16]  Giovanni Ulivi,et al.  Investigation of expert rule bases, logistic regression, and non-linear machine learning techniques for predicting response to antiretroviral treatment , 2008, Antiviral therapy.

[17]  A. Wensing,et al.  Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. , 2010, The Journal of antimicrobial chemotherapy.

[18]  Yves Moreau,et al.  Modelled in vivo HIV Fitness under drug Selective Pressure and Estimated Genetic Barrier Towards Resistance are Predictive for Virological Response , 2008, Antiviral therapy.